CSS
IPSC icon

Cubist Systematic Strategies’s Century Therapeutics IPSC Stock Holding History

Cubist Systematic Strategies’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,978
Closed -$1.1K – 3261
2025
Q2 		$1.1K Buy
+1,978
New +$1.06K ﹤0.01% 2882
2024
Q2 		– Sell
-18,907
Closed -$79K – 3477
2024
Q1 		$79K Buy
+18,907
New +$80K ﹤0.01% 3308
2023
Q1 		– Sell
-7,762
Closed -$39.8K – 4148
2022
Q4 		$39.8K Buy
+7,762
New +$73.3K ﹤0.01% 3935

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cubist Systematic Strategies's IPSC Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Century Therapeutics (IPSC) in Q3 2025, closing a stake of 1,978 shares — an estimated $1.1K sold.

Cubist Systematic Strategies first reported a position in IPSC in Q4 2022 and held it in 3 quarters. The position peaked at $79K in Q1 2024. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Century Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,978 Century Therapeutics shares in Q3 2025, an estimated $1.1K.
  • Cubist Systematic Strategies first reported a position in Century Therapeutics in Q4 2022 and held it in 3 quarters.
  • Cubist Systematic Strategies's Century Therapeutics position peaked at $79K in Q1 2024.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.